InvestorsHub Logo
Followers 52
Posts 2237
Boards Moderated 0
Alias Born 07/06/2011

Re: Doctor Detroit post# 10925

Monday, 12/05/2016 12:39:02 PM

Monday, December 05, 2016 12:39:02 PM

Post# of 16911
I'm not a PD expert per se, but work closely with several movement disorders doctors, participate in surgery for PD, and have done research on genetics, early detection of PD, and set up several PD clinical trials. It's good to pick the movement disorders doctors' brains about upcoming treatments. Sure wish I would've bought some Cynapsus and look at Neuroderm flying high today...

I have no idea about Requip (ropinirole), other than that there is high variability in how docs treat PD - some like Requip and other dopamine agonists, and some don't. One shared that they'd rather have apomorphine continuous delivery instead of ropinirole. I think all recognize that pulsatile dopaminergic stimulation via pill popping (of LD/CD or DA) is not the best answer, and that continuous stimulation is preferred. I have high hopes for our ropinirole implant, but not so much faith in our team to advance the drug in a timely fashion based on past history. We still have the best solution and technology, IMO, but that doesn't always translate into success. I think TTNP should be valued so much higher based on their continuous delivery implant technology, and eventually the market will realize that.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News